| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexrazoxane |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Sodium phytate |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Alcohol dehydrogenase inhibitor |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Ipecacuanha (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Substance with cholinesterase reactivator mechanism of action |
Is a |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Protamine (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Antidotes for pesticides (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Opioid receptor antagonist |
Is a |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Heavy metal antagonist (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Anti-heparin agent |
Is a |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Benzodiazepine receptor antagonist |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Ion exchange resin (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Mercaptamine |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Opiate antagonist poisoning NOS |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Antidote poisoning |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
1 |
| Antidote adverse reaction |
Causative agent (attribute) |
True |
Antidote (substance) |
Inferred relationship |
Some |
1 |
| Charcoal activated adverse reaction (disorder) |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Sodium nitrite adverse reaction |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Sodium thiosulfate adverse reaction |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Digoxin specific antibody adverse reaction |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Hydrofluoric acid burn antidote adverse reaction |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Allergy to antidote |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Allergy to activated charcoal |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Allergy to sodium nitrite |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Sodium thiosulfate allergy |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Allergy to digoxin immune fab (finding) |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Hydrofluoric acid burn antidote allergy |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Antidote overdose |
Causative agent (attribute) |
True |
Antidote (substance) |
Inferred relationship |
Some |
1 |
| surdose de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| surdose accidentelle de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| surdose intentionnelle de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| surdose de sulfate de protamine d'intention indéterminée |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Mesna (substance) |
Is a |
True |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing methionine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Activated charcoal oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing Fuller's earth (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Fuller's earth powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| acide édétique en sel dicobaltique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| édétate dicobaltique 15 mg/mL, ampoule de 20 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing sodium nitrite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| nitrite de sodium 30 mg/mL, ampoule de 10 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| thiosulfate de sodium 12,5 g/25 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| calcium édétate de sodium 200 mg/mL, ampoule de 5 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sodium calcium edetate 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing digoxin immune fab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Methionine 250 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| chlorhydrate d'apomorphine 10 mg/mL, ampoule de 2 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| chlorhydrate d'apomorphine 10 mg/mL, ampoule de 5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| chlorhydrate d'apomorphine 30 mg/3 mL, stylo-injecteur prérempli |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Drugs used in the treatment of paracetamol poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| acétylcystéine 200 mg/mL, ampoule de 10 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Methionine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing edetate trisodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Trisodium edetate 200mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing deferiprone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Deferiprone 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Edetate disodium 3.7 mg/g eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| agents chélateurs et antidotes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing chelating agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing edetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Hydrofluoric acid burn antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Activated charcoal powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Antidotes for pesticides |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Bentonite powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Cyanide antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing polyvalent crotalidae antivenom (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Polyvalent snake antivenin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Ammonia detoxicant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing sodium thiosulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing Micrurus fulvius antivenom (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing apomorphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing snake antivenom immunoglobulin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing edetate disodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Medicinal product acting as emetic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Medicinal product acting as antidote agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Emetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Medicinal product acting as adsorbent agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Cyanide poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Heavy metal poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Organophosphorus poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Iron poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride 2 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| médicaments utilisés pour traiter l'hyperuricémie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing rasburicase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Rasburicase 1.5mg powder and solvent for infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing potassium iodate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Potassium iodate 85 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Calcium 667mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Digoxin specific antibody 38mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing activated charcoal (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Product containing methionine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Edetate disodium anhydrous 150mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to emetics NOS |
Causative agent (attribute) |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Rasburicase 7.5mg infusion (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
| Sodium thiosulfate 12.5g/50mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]